3628 results for «384»

Filter By

3628 results

Featured research - Valves and beyond

26 Nov 2024 – From PCR London Valves 2024

This session features a selection of the latest research and insights from PCR London Valves 2024, covering a wide range of topics in valvular and structural heart interventions. Discover the early results of a new TTVR system, compare the performance of different TAVI devices, explore long-term...

Featured research - Valves and beyond

AsiaPCR/SingLIVE 2017: closing Ceremony and Awards

21 Jan 2017 – From AsiaPCR/SingLIVE 2017

Consult the Closing ceremony and awards session from AsiaPCR/SingLIVE 2017, where W. Wijns addresses the subject of what to expect in the field of Interventional Cardiology in 2017, and the speakers present the award winners of this year's best clinical cases namely R. Fukuhara, Japan, W....

Prof. Tian-Hai Koh

Chairperson

Tian Hai Koh
Rosli Mohd Ali

Chairperson

Mohd Ali Rosli
AsiaPCR/SingLIVE 2017:

AsiaPCR/SingLIVE 2017: Opening Ceremony

19 Jan 2017 – From AsiaPCR/SingLIVE 2017

Consult the Opening ceremony of the AsiaPCR/SingLIVE 2017 course edition, the Chien Foundation Award for outstanding lectureship and lifetime achievement in PCI is awarded to Prof. A. Seth.

Upendra Kaul

Chairperson

Upendra Kaul
AsiaPCR/SingLIVE 2017:

Disrupt CAD III: Safety and effectiveness of intravascular lithotripsy for treatment of severe coronary calcification

17 Oct 2020

At TCT Connect 2020, Dean Kereiakes presented the results of the Disrupt CAD III trial. Giuseppe Di Gioia and Dejan Milasinovic provide a summary of the key messages.

Giuseppe Di Gioia

Author

Giuseppe Di Gioia
Dejan Milasinovic

Author

Dejan Milasinovic
Live from TCT Connect 2020: The Disrupt CAD III trial

BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

07 Nov 2022

Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.

This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...

Nicola Ryan

Author

Nicola Ryan
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

Cardiac biomarkers in patients with asymptomatic severe aortic stenosis: primary biomarker analysis from the EARLY TAVR Trial

01 Apr 2025

Elad Asher provides his take on the primary biomarker analysis from the EARLY TAVR Trial presented by Brian R. Lindman at ACC.25 in Chicago.

Elad Asher

Author

Elad Asher
Cardiac biomarkers in patients with asymptomatic severe aortic stenosis: Primary biomarker analysis from the EARLY TAVR Trial

Surgical left atrial appendage occlusion in VHD without AF: OPINION Trial

03 Sep 2025

Alex Sticchi provides his take on the results of the OPINION trial presented by Yang Wang at the ESC Congress 2025 in Madrid.

Alessandro Sticchi

Author

Alessandro Sticchi
OPINION Trial: 1-year outcomes

Summary and take home messages of the late-breaking clinical trials presented during #TCTConnect 2020

19 Oct 2020

Vijay Kunadian provides a summary of the coronary & structural late-breaking studies presented during TCT Connect 2020 and shares some take-home messages. See how these studies might influence your daily practice!

Vijay Kunadian

Author

Vijay Kunadian
 #TCTConnect 2020 summary and take home messages
Didn’t find what you were looking for?